*/
Patent – Medicine. The Chancery Division made declarations as sought by the claimant pharmaceutical companies. It held that the initial marketing authorisation for a drug, Ribomustin, had been obtained in 2005, as contended by the claimants, rather than 2010, as contended by the defendant pharmaceutical companies. As a result, the ten-year period of delay before the claimants could market their own product had commenced in 2005, not 2010.
Patent – Medicine. The Chancery Division made declarations as sought by the claimant pharmaceutical companies. It held that the initial marketing authorisation for a drug, Ribomustin, had been obtained in 2005, as contended by the claimants, rather than 2010, as contended by the defendant pharmaceutical companies. As a result, the ten-year period of delay before the claimants could market their own product had commenced in 2005, not 2010.
Sam Townend KC explains the Bar Council’s efforts towards ensuring a bright future for the profession
Giovanni D’Avola explores the issue of over-citation of unreported cases and the ‘added value’ elements of a law report
Louise Crush explores the key points and opportunities for tax efficiency
Westgate Wealth Management Ltd is a Partner Practice of FTSE 100 company St. James’s Place – one of the top UK Wealth Management firms. We offer a holistic service of distinct quality, integrity, and excellence with the aim to build a professional and valuable relationship with our clients, helping to provide them with security now, prosperity in the future and the highest standard of service in all of our dealings.
Is now the time to review your financial position, having reached a career milestone? asks Louise Crush
If you were to host a dinner party with 10 guests, and you asked them to explain what financial planning is and how it differs to financial advice, you’d receive 10 different answers. The variety of answers highlights the ongoing need to clarify and promote the value of financial planning.
On the 50th anniversary of the pub bombings, even now it is still unresolved. Chris Mullin, the journalist and former MP who led the campaign leading to the release of the Birmingham Six, looks back at events
Adele Akers’ reflections on health and wellbeing support at the very junior end of the Bar
Not one to say, ‘I told you so,’ Sam Thomas continues his cyber series with the key learnings from the major supply chain attack affecting 80 law firms and at least one set of chambers at the end of 2023
One year on and the Court of Appeal fails to quash convictions after receiving evidence of racism in the jury room, and there are still no revisions to the Equal Treatment Bench Book , says Keir Monteith KC
Increasing sophistication and frequency of attacks have led many chambers to ask ‘when’ not ‘if’ they will suffer a cyber incident. Simon Davis sets out the factors to consider when renewing your cyber cover
